FOXO4-DRI
A designed peptide that disrupts the FOXO4-p53 interaction, selectively triggering apoptosis in senescent cells in preclinical models.
Research status: Animal-model senolytic research; a foundational 2017 paper, no human trials.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Related in Longevity